跳至主要内容
临床试验/CTRI/2025/07/091750
CTRI/2025/07/091750尚未招募Phase 3 4

Randomized Controlled clinical study of MARCEL poly herbal oral rinse in management of Oral Sub Mucous Fibrosis.

Jansuta Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年8月4日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Improvement in inter incisional distance

研究概览

简要总结

Oral Sub Mucous Fibrosis is a common chronic stomatitis leading to trismus

It may lead to leukoplakia erythroplakia and malignant changes

Satisfactory treatment is not available

MARCEL is poly herbal medicine to be used locally as oral rinse in diluted form

Drug is FDA approved and clinical trials are already done

Control drug Irimedadi oil is an Ayurvedic medicine for local use for chronic stomatitis

Multicentric controlled clinical trial is being conducted

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients of Oral Sub Mucous fibrosis.

排除标准

  • Extensive fibrosis with severe trismus within inter incisal distance less than 10 mm Disease is most advanced with premalignant and malignant changes Generalized fibromatosis Oral manifestations of scleroderma Oral lichen plants Pale Oral mucosa of anaemia mimicking blanching Chronic debilitating conditions such as TB HIV Patient not willing to give up addiction habits of Gutka pan masala tobacco etc.

结局指标

主要结局

Improvement in inter incisional distance

时间窗: Before Treatment 0 day | After treatment 60 th day

次要结局

未报告次要终点

研究者

发起方
Jansuta Pharmaceuticals
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Nisar Ali Khan

Govt Ayurved College and Hospital Nanded

研究点 (1)

Loading locations...

相似试验